Braftovi 75 mg

BRAFTOVI 75 MG capsules are a prescription medication used in combination therapy for certain types of cancer. This oral treatment is designed to target specific genetic mutations, offering a targeted approach to cancer care.

BRAFTOVI 75 MG capsules are primarily used in combination with other medications to treat advanced or metastatic cancers that harbor specific BRAF mutations. This targeted therapy is often part of a broader treatment plan for conditions like melanoma, colorectal cancer, and other solid tumors. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Common effects of BRAFTOVI 75 MG capsules may include fatigue, nausea, and skin-related issues such as rash or dry skin. Some individuals might experience changes in blood pressure or liver function. It's important to monitor these effects and report any severe or persistent symptoms to a healthcare professional.

BRAFTOVI 75 MG capsules should be handled with care, following the prescribed dosage and administration guidelines. Patients should avoid grapefruit or grapefruit juice, as it can affect the medication's effectiveness. Regular blood tests may be required to monitor liver function and other potential side effects.

BRAFTOVI 75 MG capsules can interact with a variety of medications, including those metabolized by the liver's CYP3A4 enzyme. This includes certain antidepressants, antibiotics, and antifungal medications. Alcohol and other substances that affect liver function should be avoided to prevent adverse interactions.